T否决细胞促进造血干细胞植入的研究被引量：1

Veto T Cells Enhance Engraftment Allogeneic Hematopoietic Stem Cells——Review

下载PDF

导出

摘要否决效应是一种能特异性抑制识别否决细胞自身表面抗原的细胞毒性T细胞前体细胞(CTL-p)的攻击,而CTL-p对识别第三方抗原无抑制作用。具有否决效应的细胞称为否决细胞。细胞毒性T淋巴细胞(cytotoxic Tlymphocyte,CD8+CTL)是现知否决活性最强的细胞。在异基因造血干细胞移植中,输注供者源的CD8+CTL否决细胞清除宿主同种异体反应细胞可以促进供者干细胞的植入。本文就近年来关于CD8+CTL否决效应的机制、GVH效应、抗肿瘤效应、活体内的应用及与药物和细胞之间的协同作用的研究进展做一综述。 Veto activity was defined as the capacity of specifically downregulatng cytotoxic T-precursor cell （CTL- p） directed against antigens of the veto cells themselves but not against third-party antigens. Many studies have shown that the most potent veto cells are CD8 ＋ cytotoxic T lymphocytes （ CD8＋ CTLs）. Effectively, CD8 ＋ CTLs of donor origin can facilitate engraftment of donor＇s stem cells by eliminating host-alloreactive T lymphocytes. In this article, effect mechanisms, depletion of GVH ex vivo, application in vivo, synergistic enhancement with rapamycin and regulatory T cells, and anti-tumor effect in the hematopoietic stem cell transplantation are summarized.

作者李凤段连宁纪树荃

机构地区空军总医院血液科第四军医大学研究生队

出处《中国实验血液学杂志》 CAS CSCD 2011年第3期824-827,共4页 Journal of Experimental Hematology

基金国家自然科学基金项目资助编号30873014

关键词否决细胞造血干细胞移植免疫耐受 veto cell hematopoietic stem cell transplantation immune tolerance

分类号 R457.7 [医药卫生—治疗学]

引文网络
相关文献

参考文献15

1Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature, 1980; 287 (5782) :544 - 546.
2Reich-Zeliger S, Bachar-Lustig E, Bar-Ilan A, et al. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells. J Immunol, 2007 ; 179 ( 10 ) :6389 - 6394.
3Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood, 2003; 102(6) :1943 - 1950.
4Reisner Y, Martelli MF. From "megadose" haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation. Blood cells Mol Dis, 2008 ; 40( 1 ) : 1 -7.
5Hu B, He Y, Wu Y, et al. Activated aUogeneic NK ceils as suuppressors of alloreactive responses. Biol Blood Marrow Transplant, 2010; 16(6) : 772 -781.
6Ramasamy R, Tong CK, Swow HF, et al. The immunosuppressive effects of human bone marrow-derived mesenchymal stem ceils target T cell proliferation but not its effector function. Cell Immunol, 2008 ; 251 (2) ; 131 - 136.
7Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science, 1991 ; 252(5411 ) : 1424 - 1427.
8Reich-zeliger S, Edelshtein Y, Hagin D, et al. The Role of ERK and XIAP in Tolerance Induction by Veto CTLs. Blood (ASH Annual Meeting Abstracts) 2007 ; 110 : Abstract 3256.
9Reich-Zeliger S, Eidelstein Y, Hagin D, et al. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation. Transplantation, 2010 ;90(4) :380 - 386.
10Milstein O, Lask A, Reich-Zeliger S, et al. A Novel Mechanism for CTL Mediated Veto Activity: CTLs Respond to Recognition by Alloreactive T Cell with Activation and Cytotoxic Granule Secretion. Blood (ASH Annual Meeting Abstracts), 2007; 110: 2303.